Therapeutic Segment
 Anti-lipidemic

 Generic Name
 Atorvastatin + Ezetimibe

 Indication 
 It is indicated as adjunctive therapy to diet for the reduction of elevated total-C, LDL-C, Apo B in patients with primary hypercholesterolemia and with HoFH as an adjunct to other lipid-lowering treatments or if such treatments are unavailable.

 Brand
 LipigetEZ

 Form
 Tablets